Cargando…
Methotrexate in juvenile idiopathic arthritis: advice and recommendations from the MARAJIA expert consensus meeting
BACKGROUND: Conventional pharmacological therapies for the treatment of juvenile idiopathic arthritis (JIA) consist of non-biological, disease-modifying antirheumatic drugs, among which methotrexate (MTX) is the most commonly prescribed. However, there is a lack of consensus-based clinical and thera...
Autores principales: | Ferrara, Giovanna, Mastrangelo, Greta, Barone, Patrizia, La Torre, Francesco, Martino, Silvana, Pappagallo, Giovanni, Ravelli, Angelo, Taddio, Andrea, Zulian, Francesco, Cimaz, Rolando |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6042421/ https://www.ncbi.nlm.nih.gov/pubmed/29996864 http://dx.doi.org/10.1186/s12969-018-0255-8 |
Ejemplares similares
-
Juvenile diabetes and systemic sclerosis: just a coincidence?
por: Mastrangelo, Greta, et al.
Publicado: (2022) -
Mycophenolate mofetil for methotrexate-resistant juvenile localized scleroderma
por: Martini, Giorgia, et al.
Publicado: (2020) -
Long-term methotrexate efficacy in juvenile localized scleroderma
por: Zulian, F, et al.
Publicado: (2011) -
Strategic use of levofolinic acid for methotrexate-induced side effects in juvenile idiopathic arthritis: a prospective observational study
por: Martini, Giorgia, et al.
Publicado: (2023) -
Genetic determinants for methotrexate response in juvenile idiopathic arthritis
por: Pastore, Serena, et al.
Publicado: (2015)